Tisdag 14 Oktober | 14:06:39 Europe / Stockholm

Kalender

Est. tid*
2025-08-28 - Kvartalsrapport 2025-Q2
2025-06-02 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2025-05-29 - Årsstämma
2025-04-29 - Bokslutskommuniké 2024
2025-02-12 - Extra Bolagsstämma 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-16 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2024-05-15 - Årsstämma
2024-05-07 - Bokslutskommuniké 2023
2023-10-11 - Extra Bolagsstämma 2023
2023-08-31 - Kvartalsrapport 2023-Q2
2023-05-30 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2023-05-26 - Årsstämma
2023-04-28 - Bokslutskommuniké 2022
2022-09-29 - Kvartalsrapport 2022-Q2
2022-09-02 - Extra Bolagsstämma 2022
2022-05-19 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2022-05-18 - Årsstämma
2022-04-29 - Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorHälsovård
IndustriVård & Omsorg
Brain+ är verksamt inom läkemedelsbranschen. Bolaget är specialiserat inom forskning och utveckling för behandling av demens och alzheimers. Produktportföljen inkluderar exempelvis kognitiv stimuleringsterapi. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs med störst närvaro inom Europa. Brain+ har sitt huvudkontor i Köpenhamn.
2025-10-06 08:20:00

COMPANY ANNOUNCEMENT – No. 2025-18

 

Copenhagen, Denmark, 6 October 2025 – Brain+ A/S (Nasdaq First North: BRAINP) 

Brain+ A/S (“Brain+” or the “Company”) has appointed Otto Rasmussen, an experienced financial executive, as the Company’s new Chief Financial Officer (CFO). Otto will step into the position with immediate effect, ensuring an effective hand-over from the current CFO, who will transition by end of October 2025.

Otto Rasmussen brings extensive experience in financial leadership, strategic life science business planning as well as in international development process optimization and growth strategies. He has experience from both start-ups, small and high-growth companies, private equity backed companies and publicly listed large companies.

With a strong and diversified background, Otto will play a key role in supporting Brain+’ continued commercial transition and growth as the Company is establishing a position as a leading provider of innovative digital solutions for better dementia care and therapy.

Devika Wood, CEO of Brain+, commented: ““We are delighted to welcome Otto to Brain+ at such a pivotal time in our journey. His extensive experience in financial leadership and international growth will be invaluable as we accelerate our commercial expansion and strengthen our position as a leader in digital dementia care.”

Otto Rasmussen, incoming CFO, said: I am excited to join Brain+ at such an important stage in its development. I look forward to contributing my experience to support the Company’s mission of delivering innovative digital solutions that improve dementia care and therapy.”

After the period of hand-over, Brain+ will invite investors to a webinar, where they can meet Otto and get an update on the Company’s commercial and financial outlook.

---

For more information about Brain+, please contact:

Devika Wood, CEO, E-mail: devika@brain-plus.com 

Or

Hanne Vissing Leth, CFO, Email: hanne@brain-plus.com

www.brain-plus.com

Certified Adviser

HC Andersen Capital 2 ApS

Phone: +45 28 74 66 40

E-mail: ca@hcandersencapital.dk

www.hcandersencapital.dk